Ignite Creation Date:
2024-05-06 @ 3:54 PM
Last Modification Date:
2024-10-26 @ 1:59 PM
Study NCT ID:
NCT04791150
Status:
UNKNOWN
Last Update Posted:
2021-05-10
First Post:
2021-03-05
Brief Title:
Rheumatologic Adverse Events and Cancer Immunotherapy
Sponsor:
Poitiers University Hospital
Organization:
Poitiers University Hospital
Study Overview
Official Title:
Rheumatologic Adverse Events and Immunotherapy in Oncology
Status:
UNKNOWN
Status Verified Date:
2021-05
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
In this study every patient with cancer who is going to be treated by immunotherapy will fill in a form In this form we try to determine if he presents rheumatologic complications of his immunotherapy If the patient answers yes to one question on the form the patient will be see in rheumatologic consultation to explore his clinical signs
The number of patients referred in consultation thanks to this questionnaire will be compared to the number of patients who would have been spontaneously referred by the oncologist
The aim of this questionnaire is to optimise the management of rheumatological effects secondary to immunotherapy
The number of patients referred in consultation thanks to this questionnaire will be compared to the number of patients who would have been spontaneously referred by the oncologist
The aim of this questionnaire is to optimise the management of rheumatological effects secondary to immunotherapy
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None